Skip to main content

Peer Review reports

From: MiR-31-5p alleviates septic cardiomyopathy by targeting BAP1 to inhibit SLC7A11 deubiquitination and ferroptosis

Original Submission
24 Jan 2024 Submitted Original manuscript
12 Mar 2024 Reviewed Reviewer Report - Jianqiu Pei
25 Mar 2024 Reviewed Reviewer Report
9 May 2024 Author responded Author comments - Wenqiang Li
Resubmission - Version 2
9 May 2024 Submitted Manuscript version 2
Publishing
22 May 2024 Editorially accepted
30 May 2024 Article published 10.1186/s12872-024-03954-4

You can find further information about peer review here.

Back to article page